Bo Tan - INKON Life Financial Director
| 300143 Stock | 10.36 0.07 0.67% |
Director
Bo Tan is Financial Director of INKON Life Technology
| Age | 42 |
| Address | No. 37, Chunyang Road, Qingdao, China, 266109 |
| Phone | 86 76 9879 35678 |
| Web | https://www.300143.net |
INKON Life Management Efficiency
The company has return on total asset (ROA) of 0.0335 % which means that it generated a profit of $0.0335 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0629 %, meaning that it generated $0.0629 on every $100 dollars invested by stockholders. INKON Life's management efficiency ratios could be used to measure how well INKON Life manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Intangible Assets is expected to grow to about 289.9 M, whereas Total Assets are forecasted to decline to about 1.7 B.Similar Executives
| Found 14 records | DIRECTOR Age | ||
| Xiao Qian | Youngy Health Co | 59 | |
| Fenling Xing | Youngy Health Co | 48 | |
| Zhiqiang Li | Xiangyu Medical Co | 41 | |
| Xue Yu | Ningbo Ligong Online | 45 | |
| Zhang Yi | Youngy Health Co | 49 | |
| Dicao Sun | China Reform Health | 62 | |
| Hongfeng Jin | Xiangyu Medical Co | 51 | |
| Junling Guo | Xiangyu Medical Co | 52 | |
| Xu Jinguo | Nanjing Vishee Medical | 47 | |
| Xing Fenling | Youngy Health Co | 48 | |
| Jinguo Xu | Nanjing Vishee Medical | 48 | |
| Yingjie Liu | China Reform Health | 53 | |
| Wenlong Liu | Nanjing Vishee Medical | 37 | |
| Xiaofeng Li | Huaxia Eye Hospital | 53 | |
Management Performance
| Return On Equity | 0.0629 | ||||
| Return On Asset | 0.0335 |
INKON Life Technology Leadership Team
Elected by the shareholders, the INKON Life's board of directors comprises two types of representatives: INKON Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of INKON. The board's role is to monitor INKON Life's management team and ensure that shareholders' interests are well served. INKON Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, INKON Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bo Tan, Financial Director | ||
| Wen Peng, GM Director | ||
| Jinchen Xie, Accounting Supervisor | ||
| Hongbo Li, Deputy Manager | ||
| Lan Jiang, Financial Director | ||
| Yuanyuan Hu, Board Sec | ||
| Zelin Liu, Board Secretary |
INKON Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is INKON Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0629 | ||||
| Return On Asset | 0.0335 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 7.82 B | ||||
| Shares Outstanding | 749.45 M | ||||
| Shares Owned By Insiders | 42.69 % | ||||
| Shares Owned By Institutions | 2.61 % | ||||
| Price To Book | 5.49 X | ||||
| Price To Sales | 4.91 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in INKON Stock
INKON Life financial ratios help investors to determine whether INKON Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in INKON with respect to the benefits of owning INKON Life security.